Unknown

Dataset Information

0

Reversine, a selective MPS1 inhibitor, induced autophagic cell death via diminished glucose uptake and ATP production in cholangiocarcinoma cells.


ABSTRACT: Reversine is a selective inhibitor of mitotic kinase monopolar spindle 1 (MPS1) and has been reported as an anticancer agent in various cancers. The effects of reversine on bile duct cancer, cholangiocarcinoma (CCA), a lethal cancer in Northeastern Thailand, were investigated. This study reports that reversine inhibited cell proliferation of CCA cell lines in dose- and time-dependent manners but had less inhibitory effect on an immortalized cholangiocyte cell line. Reversine also triggered apoptotic cell death by decreasing anti-apoptotic proteins, Bcl-XL and Mcl-1, increasing Bax pro-apoptotic protein and activating caspase-3 activity. Moreover, reversine induced autophagic cell death by increasing LC3-II and Beclin 1 while decreasing p62. Reversine activated autophagy via the AKT signaling pathway. Additionally, this study demonstrated for the first time that reversine could diminish the expression of Hypoxia-Inducible Factor 1- alpha (HIF-1α) and glucose transporter 1 (GLUT1), resulting in a reduction of glucose uptake and energy production in CCA cell lines. These findings suggest that reversine could be a good candidate as an alternative or supplementary drug for CCA treatment.

SUBMITTER: Prajumwongs P 

PROVIDER: S-EPMC7797171 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC1458776 | biostudies-literature
2023-01-09 | GSE190697 | GEO
| S-EPMC9809967 | biostudies-literature
| S-EPMC3417315 | biostudies-literature
| S-EPMC3760778 | biostudies-literature
| S-EPMC5807212 | biostudies-literature
2018-10-25 | GSE106174 | GEO
| S-EPMC5790487 | biostudies-literature
| S-EPMC5951017 | biostudies-literature
2023-03-22 | GSE188535 | GEO